The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)--why and what?
BACKGROUND
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published a strategy for diagnosis and for management of chronic obstructive pulmonary disease (COPD) since 2001 and this has formed the basis for numerous national and regional guidelines.


OBJECTIVE
We describe the background for the 2011 revision of the GOLD document.


METHODS
The GOLD document is updated annually and revised every 5 years based on published research as well as an evaluation by an expert panel of how to best formulate and disseminate knowledge on COPD.


RESULTS
The GOLD 2011 revision states that spirometry is required for making a clinical diagnosis of COPD. At the same time, the document has less emphasis on spirometric evaluation of disease severity and launches a combined assessment taking symptoms, spirometry and history of exacerbations into account. This is matched with initial treatment for COPD where smoking cessation, pulmonary rehabilitation and physical activity in general are given high priority followed by pharmacologic treatment guided by the novel assessment scheme. Comorbidities are often present in COPD and the GOLD 2011 revision gives some guidance in how to manage these as well as how to manage COPD in the presence of comorbidities.


CONCLUSIONS
A more clinically oriented GOLD document will hopefully improve assessment and management of COPD.
Department of Respiratory Medicine J, Odense University Hospital, Odense, Denmark. jvestbo@dadlnet.dk
Jørgen
J
Vestbo
Suzanne S
SS
Hurd
Roberto
R
Rodriguez-Roisin
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D015897:Comorbidity; D018450:Disease Progression; D015444:Exercise / Q000502:physiology; D005260:Female; D014943:Global Health; D006801:Humans; D008019:Life Style; D008297:Male; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000592:standards*; D011379:Prognosis; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000517:prevention & control* / Q000628:therapy*; D012129:Respiratory Function Tests; D012307:Risk Factors; D012720:Severity of Illness Index; D016540:Smoking Cessation / Q000379:methods; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D001993:Bronchodilator Agents